MedPath

AAT + tDCS to Reduce Cue-induced Craving and Smoking Behavior

Not Applicable
Completed
Conditions
Smoking Behaviors
Smoking, Cigarette
Interventions
Behavioral: Approach/Avoidance Task
Device: Sham tDCS
Behavioral: AC
Device: Transcranial Direct Current Stimulation
Registration Number
NCT05426460
Lead Sponsor
Cynthia Conklin
Brief Summary

Smokers are highly reactive to smoking-related stimuli and report that this cue reactivity (CR) is a major obstacle to quitting. To date, no pharmacologic methods attenuate CR, and attempts to diminish it with traditional cue exposure treatment (CET) have not proven effective. The proposed study will test a highly novel cue-based smoking treatment adjunct combining an Approach/Avoidance Task (AAT) with brain stimulation via tDCS applied to the dorsolateral prefrontal cortex (dlPFC) during personalized multi-cue exposure; the goal of which is to discover an effective means of reducing cue reactivity and daily smoking, and increasing intent and confidence to quit, among high treatment-interest smokers.

Detailed Description

Exposure to smoking-related cues robustly increases self-report craving and immediate subsequent smoking. This cue-reactivity (CR) is an often-reported obstacle to quitting among smokers. Unlike methods to diminish abstinence-induced craving, which have been highly successful with the advent of nicotine replacement therapies (NRTs), pharmacotherapies have not been shown to diminish smoking-related reactivity to cues. Past behavioral methods to reduce smokers' CR, most commonly extinction training through cue-exposure treatment (CET), have also consistently failed. Review of past CET studies reveals that this failure is largely due to several methodological shortcomings including: (1) presenting only proximal cues (e.g., cigarettes, ashtrays), (2) conducting passive unreinforced exposure to these limited cues, and (3) achieving only limited new learning. The researchers extensive past cue work makes them uniquely qualified to remedy these flaws by designing and testing novel CET methodology incorporating contemporary techniques and technology to reduce CR and relieve smokers of this ubiquitous source of relapse risk. The researchers propose three methods to improve CET. First, using well-tested methods for personalizing smoking cues and presenting numerous proximal, environment, and people cues in combination, the proposed cue exposure will better capture and target the cue-rich situations most likely to trigger smokers' strongest CR. Second, rather than repeated passive unreinforced exposure to cues, smokers will engage in active re-training of approach biases toward their personal smoking stimuli using an Approach/Avoidance Task (AAT), a method shown to activate the dorsolateral prefrontal cortex (dlPFC), a brain region associated with both cognitive control over craving and deactivation of drug reward systems. Third, to enhance new learning, smokers will undergo non-invasive transcranial direct current brain stimulation (i.e., tDCS) of the dlPFC. Although the researchers propose each method, AAT and tDCS, should independently reduce smokers' CR to their most salient cues, providing AAT with simultaneous tDCS (AAT+tDCS) should synergistically attenuate CR by better increasing cortical excitability in the dlPFC. To assess this, a 2 x 2 active and sham-controlled test of AAT and tDCS during personalized multi-cue exposures will be used to examine pre-post training changes across several measures of smoking-related cue reactivity (cue-induced craving, cue-provoked smoking topography, and attentional bias measures of Evoked Response Potentials (ERPs) and reaction time), as well as changes in daily smoking and confidence and intent to quit pre-post training and at 1 week and 1-month follow up. The goal of this work is to develop an efficacious treatment adjunct that better prepares smokers to confront cues when they try to remain quit.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
41
Inclusion Criteria
  • Between the ages of 26 & 55
  • High treatment interest (planning to quit within the next 6 months)
  • Ability to provide written informed consent
  • Smoke equal or greater than 7 cigarettes per day
  • Expired breath carbon monoxide (CO) equal or greater than 8 ppm at screening
  • Ability to attend 10 sessions over a 3-week period, and complete 2 follow-up phone assessments
Exclusion Criteria
  • Epilepsy or Current Seizure Disorder
  • Alcohol or Substance Dependence past 3 months (caffeine allowed, nicotine is part of inclusion criteria, alcohol > 14 drinks per week (M) or > 7 drinks per week (F))
  • Implanted cardiac or brain medical devices
  • History of epilepsy or current seizure disorder
  • History of brain surgery or skull fracture
  • History of a head trauma (losing consciousness >10 min and/or problems with speech or movement because of head injury)
  • Latex allergy
  • Scalp irritation
  • History of diabetes that caused loss of consciousness (>10 min) or weakness in your arms or legs
  • History of electroconvulsive therapy (ECT) in the last 5 years (Y / N) History of ECT within the last 5 years
  • Current use of dextromethorphan
  • Diagnosed with or undergone treatment for alcohol or substance dependence past 3 months
  • Uncorrected vision deficit
  • Colorblindness
  • Use of tobacco products other than commercially available cigarettes

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
AAT + sham tDCSSham tDCSApproach Avoidance Task with Sham Transcranial Direct Current Stimulation.
AC + sham tDCSSham tDCSActive Control Task with sham Transcranial Direct Current Stimulation
AAT + sham tDCSApproach/Avoidance TaskApproach Avoidance Task with Sham Transcranial Direct Current Stimulation.
AAT + tDCSApproach/Avoidance TaskApproach Avoidance Task + Transcranial Direct Current Stimulation targeting the dorsolateral prefrontal cortex
AC + tDCSACActive Control Task with Transcranial Direct Current Stimulation targeting the dorsolateral prefrontal cortex
AAT + tDCSTranscranial Direct Current StimulationApproach Avoidance Task + Transcranial Direct Current Stimulation targeting the dorsolateral prefrontal cortex
AC + tDCSTranscranial Direct Current StimulationActive Control Task with Transcranial Direct Current Stimulation targeting the dorsolateral prefrontal cortex
AC + sham tDCSACActive Control Task with sham Transcranial Direct Current Stimulation
Primary Outcome Measures
NameTimeMethod
Mean Change from baseline in rating score for 5-item Intent to Quit QuestionnaireBaseline to approximately 6-weeks

Difference between Intent to Quit rating from pre-treatment (Baseline) to 1 month post-treatment (follow-up)

Mean Change from baseline in rating score for Confidence to Quit QuestionnaireBaseline to approximately 6-weeks

Difference between Confidence to Quit score from pre-treatment (Baseline) to 1 month post-treatment (follow-up)

Mean Change from baseline in 4-item Questionnaire on Smoking Urges craving score during cue reactivity to personal cuesBaseline to approximately 1 week

Difference between cue-induced craving rating from pre-treatment (Baseline) to post-treatment (re-test)

Mean Change from baseline in number cigarettes smoked dailyBaseline to approximately 6-weeks

Difference in mean number of cigarette smoker per day from pre-treatment (Baseline) to 1 month post treatment (follow-up)

Secondary Outcome Measures
NameTimeMethod
Sex as a moderator of cigarettes smoked per dayBaseline to approximately 6 weeks

The correlation between sex (male / female) and change in number of cigarettes smoked per day from pre-training to 1 month follow-up.

Sex as a moderator of cue-induced cravingBaseline to approximately 1 week

The correlation between sex (male / female) and QSU-rating difference score (craving rating to smoking cues minus craving to neutral cues) from pre- to post training.

Age as a moderator of cue-induced cravingBaseline to approximately 1 week

The correlation between QSU-rating difference score (craving rating to smoking cues minus craving to neutral cues) from pre- to post training.

Age as a moderator of of cigarettes smoked per dayBaseline to approximately 6 weeks

The correlation between change in number of cigarettes smoked per day from pre-training to 1 month follow-up.

Baseline measure of Fagerstrom Test of Nicotine Dependence (FTND) as moderator of cue-induced craving.Baseline to approximately 1 week

The correlation between Fagerstrom Test of Nicotine Dependence (FTND)and QSU-rating difference score (craving rating to smoking cues minus craving to neutral cues) from pre- to post training.

Baseline measure of Fagerstrom Test of Nicotine Dependence (FTND) as moderator of cigarettes per dayBaseline to approximately 6 weeks

The correlation between Fagerstrom Test of Nicotine Dependence (FTND) as a predictor of change in number of cigarettes smoked per day from pre-training to 1-month follow-up.

Trial Locations

Locations (1)

University of Pittsburgh

🇺🇸

Pittsburgh, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath